EVs carrying tumor peptides presented by MHC class I and II complexes can directly stimulate CD4+ and CD8+ T cells, or indirectly stimulate T cells by interacting with antigen-presenting cells, playing immunostimulatory or immunosuppressive roles [10–15]. The gene discussed is CD8A; the disease is neoplasm.